Discover 1,431 paid clinical trials in St. Petersburg, Florida. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 1,431
Project: Every Child for Younger Patients With Cancer
for
Adrenal Gland Pheochromocytoma, Carcinoma In Situ,
Location: St. Petersburg FL, Tampa FL, Orlando FL, Fort Myers FL,
Sponsor: Children's Oncology Group
Sex: All
Age: 0 - 25
Code: NCT02402244
Recruiting
Thoracotomy Versus Thoracoscopic Management of Pulmonary Metastases in Patients With Osteosarcoma
for
Metastatic Malignant Neoplasm in the Lung,
Location: St. Petersburg FL, Tampa FL, Orlando FL, Fort Myers FL,
Sponsor: Children's Oncology Group
Sex: All
Age: 0 - 50
Code: NCT05235165
Phase 3, Recruiting
A Study to Compare Standard Chemotherapy to Therapy With CPX-351 and/or Gilteritinib for Patients With Newly Diagnosed AML With or Without FLT3 Mutations
for
Acute Myeloid Leukemia
Location: St. Petersburg FL, Tampa FL, Orlando FL, Fort Myers FL,
Sponsor: Children's Oncology Group
Sex: All
Age: 0 - 21
Code: NCT04293562
Phase 3, Recruiting
Testing the Addition of the Anti-cancer Drug Venetoclax and/or the Anti-cancer Immunotherapy Blinatumomab to the Usual Chemotherapy Treatment for Infants With Newly Diagnosed KMT2A-rearranged or KMT2A-non-rearranged Leukemia
for
Acute Leukemia of Ambiguous Lineage,
Location: St. Petersburg FL, Tampa FL, Orlando FL, Gainesville FL,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 0 - 1
Code: NCT06317662
Phase 2, Recruiting
Study of Lurbinectedin Monotherapy in Pediatric and Young Adult Participants With Relapsed/Refractory Ewing Sarcoma
Location: Saint Petersburg FL, Nashville TN, Cincinnati OH,
Sponsor: New York Medical College
Sex: All
Age: 0 - 21
Code: NCT02249923
Recruiting
Study of Trastuzumab Deruxtecan With Bevacizumab Versus Bevacizumab Monotherapy for First-line Maintenance in HER2-Expressing Ovarian Cancer (DESTINY-Ovarian01)
for
Ovarian Cancer
Location: St. Petersburg FL, Orlando FL, Jupiter FL,
Sponsor: Daiichi Sankyo
Sex: Female
Age: 18+
Code: NCT06819007
Phase 3, Recruiting
Implementation pRogram to Improve Screening and Management for CKD in Diabetes (Program 1) (IRIS-CKD)
for
Chronic Kidney Disease(CKD), Type 2 DM,
Location: St. Petersburg FL, Birmingham AL, Houston NC, Durham NC,
Sponsor: Duke University
Sex: All
Age: 18+
Code: NCT06906627
Recruiting
Implementation pRogram to Improve Screening and Management for CKD in Diabetes (IRIS-CKD) (Program 2)
for
Chronic Kidney Disease(CKD), Type 2 DM,
Location: St. Petersburg FL, Birmingham AL, Durham NC, Houston TX,
Sponsor: Duke University
Sex: All
Age: 18+
Code: NCT06906640
Recruiting
Treatment for Youth (Ages 8 to 16 Years Old) With Misophonia (U-HEAR)
for
Misophonia
Location: Saint Petersburg FL, Coral Gables FL
Sponsor: University of South Florida
Sex: All
Age: 8 - 16
Code: NCT04365543
Recruiting
Safety and Tolerability Trial of Lumateperone in Pediatric Patients With Schizophrenia, Bipolar Disorder or Autism Spectrum Disorder
Location: St. Petersburg FL, Miami FL, Gainesville FL,
Sponsor: Intra-Cellular Therapies, Inc.
Sex: All
Age: 5 - 17
Code: NCT06229210
Phase 3, Recruiting
Multicenter Study of Lumateperone for the Treatment of Irritability Associated With Autism Spectrum Disorder (ASD) in Pediatric Patients
for
Irritability Associated With Autism Spectrum Disorder
Location: St. Petersburg FL, Orlando FL, Pompano Beach FL,
Sponsor: Intra-Cellular Therapies, Inc.
Sex: All
Age: 5 - 17
Code: NCT06706674
Phase 3, Recruiting
Treatment of Anxiety in Late Adolescents With Autism
for
Autism Spectrum Disorder
Location: Saint Petersburg FL
Sponsor: University of South Florida
Sex: All
Age: 16 - 21
Code: NCT02977962
Recruiting
Evaluate Bacteriophage as a Useful Immunogen in Patients With Primary Immune Deficiency Diseases (PIDD)
for
Primary Immune Deficiency Diseases
Location: St. Petersburg FL
Sponsor: University of South Florida
Sex: All
Age: 2 - 70+
Code: NCT01617122
Recruiting
A Study of Mavorixafor in Participants With Congenital and Acquired Primary Autoimmune and Idiopathic Chronic Neutropenic Disorders Who Are Experiencing Recurrent and/or Serious Infections
for
Neutropenia
Location: St. Petersburg FL, Atlanta GA, Durham NC, Woodland TX,
Sponsor: X4 Pharmaceuticals
Sex: All
Age: 12+
Code: NCT06056297
Phase 3, Recruiting
A Study Evaluating Ficerafusp Alfa (BCA101) QW in Combination With Pembrolizumab vs Alternative Ficerafusp Alfa Dosing in 1L R or M HNSCC
for
Metastatic Head and Neck Squamous Cell Carcinoma,
Location: St. Petersburg FL, Fort Myers FL, Orlando FL,
Sponsor: Bicara Therapeutics
Sex: All
Age: 18+
Code: NCT07807163
Phase 2, Recruiting
A Study to Evaluate Efficacy, Safety, and PK of XEMBIFY®+Standard Medical Treatment (SMT) Compared to Placebo+SMT to Prevent Infections in Participants With HGG and Recurrent or Severe Infections Associated With B-cell Chronic Lymphocytic Leukemia, Multiple Myeloma, and Non-Hodgkin Lymphoma
for
Hypogammaglobulinemia, Bacterial Infections,
Location: St. Petersburg FL, Morrisville NC, Wilson NC,
Sponsor: Grifols Therapeutics LLC
Sex: All
Age: 18+
Code: NCT05645107
Phase 3, Recruiting
A Study to Evaluate the Clinical Outcomes of Efgartigimod PH20 SC in Adults With New-onset Generalized Myasthenia Gravis (gMG)
for
New Onset Generalized Myasthenia Gravis (gMG)
Location: St. Petersburg FL, Port Charlotte FL, Orange FL,
Sponsor: argenx
Sex: All
Age: 18+
Code: NCT06909214
Recruiting
Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer